Sign Up for a Free Account
  • Updated 03.24.2024
  • Released 03.16.1994
  • Expires For CME 03.24.2027

Leptospirosis

Introduction

Overview

Leptospirosis is a common and significantly underdiagnosed multisystem zoonotic infection, most often presenting with conjunctival suffusion and myalgias. Although usually self-limited, it can pose a serious threat to patients and a management challenge to clinicians. The author reviews the range of clinical manifestations of this infection, with particular emphasis on the uncommon but potentially serious forms of nervous system leptospirosis. Diagnostic and therapeutic strategies are reviewed in detail.

Key points

• Leptospirosis is a common zoonosis, resulting in 1,000,000 severe infections and 60,000 deaths worldwide annually.

• Leptospirosis is typically spread in warm weather months through contact with bodies of water contaminated with urine or feces of infected rodents or other animals.

• Common clinical manifestations include conjunctival suffusion, headache, and myalgias.

• The illness tends to be biphasic, with the immune response playing an important pathogenic role in the second phase.

• The causative organism is responsive to multiple antibiotics, including penicillins and tetracyclines.

• Multiorgan damage, and even death, occurs in severe cases.

Historical note and terminology

In 1886, Weil described a clinical syndrome that now bears his name. Twenty-one years later, the leptospirosis spirochete was first visualized in the kidney of a patient who had died during a yellow fever epidemic (59). In 1916, two different groups isolated leptospires from Japanese mine workers and from subjects in France suffering from German trench disease (25; 61).

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125